Gsa Capital Partners LLP Anika Therapeutics, Inc. Transaction History

Gsa Capital Partners LLP

  • $1.35 Billion
  • Q4 2024

A detailed history of Gsa Capital Partners LLP transactions in Anika Therapeutics, Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 11,576 shares of ANIK stock, worth $175,492. This represents 0.01% of its overall portfolio holdings.

Number of Shares
11,576
Previous 31,475 63.22%
Holding current value
$175,492
Previous $777,000 75.42%
% of portfolio
0.01%
Previous 0.06%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 07, 2025
SELL
$16.04 - $25.53 $319,179 - $508,021
-19,899 Reduced 63.22%
11,576 $191,000
Q3 2024

Nov 05, 2024
SELL
$24.25 - $28.75 $196,109 - $232,501
-8,087 Reduced 20.44%
31,475 $777,000
Q2 2024

Aug 15, 2024
SELL
$24.57 - $28.47 $105,036 - $121,709
-4,275 Reduced 9.75%
39,562 $1 Million
Q1 2024

May 03, 2024
SELL
$21.95 - $26.42 $319,131 - $384,120
-14,539 Reduced 24.91%
43,837 $1.11 Million
Q4 2023

Feb 16, 2024
BUY
$18.47 - $23.3 $124,450 - $156,995
6,738 Added 13.05%
58,376 $1.32 Million
Q3 2023

Nov 15, 2023
BUY
$16.98 - $26.1 $876,813 - $1.35 Million
51,638 New
51,638 $962,000
Q1 2023

May 12, 2023
BUY
$25.91 - $32.1 $485,268 - $601,200
18,729 New
18,729 $537,000
Q1 2022

May 11, 2022
SELL
$24.7 - $36.54 $240,009 - $355,059
-9,717 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$35.83 - $45.03 $347,694 - $436,971
-9,704 Reduced 49.97%
9,717 $348,000
Q3 2021

Nov 12, 2021
SELL
$38.75 - $44.47 $830,567 - $953,169
-21,434 Reduced 52.46%
19,421 $827,000
Q2 2021

Aug 05, 2021
BUY
$39.42 - $48.08 $1.04 Million - $1.27 Million
26,385 Added 182.34%
40,855 $1.77 Million
Q1 2021

May 10, 2021
BUY
$32.49 - $45.96 $470,130 - $665,041
14,470 New
14,470 $590,000
Q2 2020

Aug 11, 2020
SELL
$27.83 - $37.73 $313,727 - $425,330
-11,273 Closed
0 $0
Q1 2020

May 12, 2020
BUY
$22.38 - $54.06 $37,195 - $89,847
1,662 Added 17.29%
11,273 $326,000
Q4 2019

Feb 12, 2020
BUY
$51.85 - $73.36 $1,088 - $1,540
21 Added 0.22%
9,611 $498,000
Q3 2019

Nov 12, 2019
SELL
$40.05 - $57.47 $16,660 - $23,907
-416 Reduced 4.16%
9,590 $526,000
Q2 2019

Aug 06, 2019
BUY
$30.3 - $41.14 $303,181 - $411,646
10,006 New
10,006 $406,000
Q1 2019

May 15, 2019
SELL
$29.37 - $40.49 $399,373 - $550,583
-13,598 Closed
0 $0
Q4 2018

Feb 12, 2019
BUY
$30.16 - $43.0 $244,899 - $349,160
8,120 Added 148.23%
13,598 $457,000
Q3 2018

Nov 13, 2018
BUY
$32.83 - $42.51 $179,842 - $232,869
5,478 New
5,478 $231,000

Others Institutions Holding ANIK

# of Institutions
110
Shares Held
11.1M
Call Options Held
1.8K
Put Options Held
1.9K
View Full List

About Anika Therapeutics, Inc.

ANIK Quotes by TradingView
  • Ticker ANIK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,599,900
  • Market Cap $221M
  • Description
  • Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...
More about ANIK
Track This Portfolio

Track Gsa Capital Partners LLP Portfolio

Follow Gsa Capital Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email